Risk assessment for Creutzfeldt-Jakob disease [11]

Lancet

Volumn 360, Issue 9338, 2002, Pages 1026-

  Struthers, J K ^a   Weinbren, M J ^a   Lockwood, J ^a   Glancy, S ^a   O'Connell, N H ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BRAIN DISEASE; CREUTZFELDT JAKOB DISEASE; DONOR; ENDOSCOPY; HEALTH CARE PERSONNEL; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; INCIDENCE; LETTER; NEUROSURGERY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0037190585     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)11116-0     Document Type: Letter

References (2)

1. Advisory Committee on Dangerous Pathogens: Spongiform Encephalopathy Advisory Committee. Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection. London: Stationery Office, 1998: 1-54.
2. CJD Incidents Panel. Management of Possible Exposure to CJD Through Medical Procedures: A Consultation Paper. London: Department of Health Publications, 2002: 1-62.